close
close

Dr. Kelly on the importance of testing for genetic abnormalities in GIST


Dr. Kelly on the importance of testing for genetic abnormalities in GIST

Ciara Kelly, MBBCh, BAO, interim clinical director of the Sarcoma Oncology Service at Memorial Sloan Kettering Cancer Center (MSKCC), discusses the management of patients with gastrointestinal stromal tumors (GISTs), emphasizing the importance of testing for genetic abnormalities and explaining how she performs this testing in her own clinical practice. When treating patients with GIST, it […]